Vitamin D Deficiency, New England Journal of Medicine, vol.357, issue.3, pp.266-281, 2007. ,
DOI : 10.1056/NEJMra070553
Vitamin D: beyond bone, Annals of the New York Academy of Sciences, vol.88, issue.7, pp.45-58, 2013. ,
DOI : 10.1111/nyas.12129
Rare Causes of Calcitriol-Mediated Hypercalcemia: A Case Report and Literature Review, The Journal of Clinical Endocrinology & Metabolism, vol.95, issue.7, pp.3111-3117, 2010. ,
DOI : 10.1210/jc.2009-2673
Genetic Disorders and Defects in Vitamin D Action, Endocrinology and Metabolism Clinics of North America, vol.39, issue.2, pp.333-346, 2010. ,
DOI : 10.1016/j.ecl.2010.02.004
Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness, Journal of Bone and Mineral Research, vol.73, issue.4535, pp.2341-2357, 2011. ,
DOI : 10.1002/jbmr.463
Renal mass and reserve of vitamin D: Determinants in primary hyperparathyroidism, Kidney International, vol.31, issue.5, pp.1174-1180, 1987. ,
DOI : 10.1038/ki.1987.125
Vitamin D, AJP: Renal Physiology, vol.289, issue.1, pp.8-28, 2005. ,
DOI : 10.1152/ajprenal.00336.2004
Vitamin D Metabolism in Hypoparathyroidism, The Journal of Clinical Endocrinology & Metabolism, vol.51, issue.3, pp.606-610, 1980. ,
DOI : 10.1210/jcem-51-3-606
Quantification of circulating 1,25 dihydroxyvitamin D by radio-immunoassay with an 125 I-labeled tracer, Clin Chem, vol.45, pp.586-592, 1996. ,
Measurement of Plasma 1,25 Dihydroxyvitamin D Using a Novel Immunoextraction Technique and Immunoassay with Iodine Labelled Vitamin D Tracer, Annals of Clinical Biochemistry: An international journal of biochemistry and laboratory medicine, vol.34, issue.6, pp.632-637, 1997. ,
DOI : 10.1177/000456329703400606
Development of a method for the quantification of 1??,25(OH)2???vitamin D3 in serum by liquid chromatography tandem mass spectrometry without derivatization, European Journal of Mass Spectrometry, vol.16, issue.1, pp.81-89, 2010. ,
DOI : 10.1255/ejms.1024
Quantification of 1??,25-Dihydroxy Vitamin D by Immunoextraction and Liquid Chromatography-Tandem Mass Spectrometry, Clinical Chemistry, vol.57, issue.9, pp.1279-1285, 2011. ,
DOI : 10.1373/clinchem.2010.161174
Experience with the first fully automated chemiluminescence immunoassay for the quantification of 1a,25-dihydroxy-vitamin D, Clin Chem Lab Med, vol.53, pp.761-770, 2015. ,
Bone Mineral Density Evolution After Successful Parathyroidectomy in Patients With Normocalcemic Primary Hyperparathyroidism, The Journal of Clinical Endocrinology & Metabolism, vol.98, issue.8, pp.3213-3233, 2013. ,
DOI : 10.1210/jc.2013-1518
Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-ofconcept and safety study, Nephrol Dial Transplant, vol.28, pp.1779-1786, 2013. ,
Effect of outliers and non healthy individuals on reference interval estimation, Clin Chem, pp.2137-3145, 2001. ,
Familial hypocalciuric hypercalcemia-observation on vitamin D metabolism and parathyroid function ,
Vitamin D Metabolism in Familial Benign Hypercalcemia (Hypocalciuric Hypercalcemia) Differs from That in Primary Hyperparathyroidism*, The Journal of Clinical Endocrinology & Metabolism, vol.58, issue.4, pp.744-747, 1984. ,
DOI : 10.1210/jcem-58-4-744
Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism, Eur J Endocrinol, vol.159, pp.719-727, 2008. ,
Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism, Clinical Endocrinology, vol.1, issue.2, pp.707-715, 2008. ,
DOI : 10.1210/jc.2004-1772
Determinants of the serum concentration of 1,25-dihydroxyvitamin D in primary hyperparathyroidism, Clinical Science, vol.76, issue.1, pp.81-86, 1989. ,
DOI : 10.1042/cs0760081
Circulating concentrations of 1,25-dihydroxyvitamin D3 in patients with primary hyperparathyroidism, Bone and Mineral, vol.1, pp.137-144, 1986. ,
Biochemical variables associated with bone density in patients with primary hyperparathyroidism, Eur J Surgery, vol.158, pp.473-476, 1992. ,
Recovery of bone mineral density in 126 ,
Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation., Journal of Clinical Investigation, vol.63, issue.2, pp.342-344, 1979. ,
DOI : 10.1172/JCI109308
Regulation of Vitamin D Metabolism in Normal Human Pregnancy*, The Journal of Clinical Endocrinology & Metabolism, vol.56, issue.2, pp.363-370, 1983. ,
DOI : 10.1210/jcem-56-2-363
Changes in calciotropic hormones, bone markers and insulin-like growth factor I (IGF-I) during pregnancy and postpartum: a controlled cohort study, Osteoporos Int, vol.24, pp.1307-1320, 2013. ,
by Human Placenta in Vitro*, The Journal of Clinical Endocrinology & Metabolism, vol.53, issue.3, pp.484-488, 1981. ,
DOI : 10.1210/jcem-53-3-484
Plasma Vitamin D Metabolite Concentrations in Chronic Renal Failure: Effect of Oral Administration of 25-Hydroxyvitamin D3*, The Journal of Clinical Endocrinology & Metabolism, vol.59, issue.6, pp.1063-1069, 1984. ,
DOI : 10.1210/jcem-59-6-1063
Evidence for Persistent Vitamin D 1-Alpha-Hydroxylation in Hemodialysis Patients: Evolution of Serum 1,25-Dihydroxycholecalciferol after 6 Months of 25-Hydroxycholecalciferol Treatment, Nephron Clinical Practice, vol.110, issue.1, pp.58-65, 2008. ,
DOI : 10.1159/000151534
Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation, Nephrology Dialysis Transplantation, vol.24, issue.12 ,
DOI : 10.1093/ndt/gfp370
Hypercalcemia in an Anephric Patient with Sarcoidosis: Evidence for Extrarenal Generation of 1,25-Dihydroxyvitamin D, New England Journal of Medicine, vol.305, issue.8, pp.440-443, 1981. ,
DOI : 10.1056/NEJM198108203050807
Extra-renal production of calcitriol in chronic renal failure, Kidney International, vol.34, issue.3, pp.368-375, 1988. ,
DOI : 10.1038/ki.1988.190
0) Serum calcium (mmol/L) 2.30 ± 010-2.60) Serum phosphate, pp.20-26 ,